After learning doctors weren’t prescrbing its migraine drug Nurtec because they assumed insurance coverage would be a hassle, the company created a phone line for doctors and patients to call Pfizer (PFE) directly for help, Jared Hopkins of The Wall Street Journal reports. The company credits that, along with some other changes, for a 31% increase in Nurtec’s U.S. sales last year.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- Concerns increase around adverse effects of benzodiazepines, WSJ says
- Biotech Alert: Searches spiking for these stocks today
- Arvinas price target lowered to $12 from $48 at Morgan Stanley
- ViiV announces new study data showing zero HIV cases with Apretude
- ViiV Healthcare announces data from EMBRACE Phase IIb study
Questions or Comments about the article? Write to editor@tipranks.com